 |
2-Pyrazinecarbonitrile, 5-[[5-2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino] monomesylate monohydrate |
|---|---|
| Trade Name | |
| Orphan Indication | Anal cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-04-09 00:00:00 |
| Sponsor | Eli Lilly and Company;Lilly Corporate Center;Indianapolis, Indiana, 46285 |
